Metascreen is an advanced non-invasive metabolic screening test distributed by Cordlife Group Limited ("Cordlife"). It can detect as many as 110 inborn errors of metabolism ("IEMs", or metabolic disorders) from a urine specimen. Cordlife owns the brand name and trademark, "Metascreen". Metascreen, as a newborn metabolic screening test, was first launched by Cordlife in India in October 2013. Since April 2014, Metascreen became available also in Hong Kong and the Philippines through Cordlife for parents looking for more comprehensive screening of metabolic disorders for their children. As a newborn suffering from certain metabolic disorder, such as isovaleric acidemia, may appear asymptomatic in the first few days or even weeks of life, early detection and treatment is key in preventing irreversible lifelong complications, such as physical disability or mental retardation. More information...
According to PR-model, metascreen.org is ranked 2,968,546th in multilingual Wikipedia, in particular this website is ranked 1,608,854th in English Wikipedia.
The website is placed before egypttravelsearch.net and after office-breath.com in the BestRef global ranking of the most important sources of Wikipedia.
